Table 2.
Time 1 (Baseline) | Time 2 | Time 3 | Time 4 | Results of GEE Analyses | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|
TAUM (SD) | SDPM (SD) | TAUM (SD) | SDPM (SD) | TAUM (SD) | SDPM (SD) | TAUM (SD) | SDPM (SD) | Time 2 B(SE) | Time 3 B(SE) | Time 4 B(SE) | |
Provider use of clinical practice strategies for diversion prevention | |||||||||||
Provider discussed diversion prevention | 9.86(6.30) | 9.11(6.83) | 10.52(7.04) | 11.18(7.31) | 12.05(7.14) | 12.40(7.05) | 11.76(7.32) | 13.45(7.06) | .32(.16) * | .18(.17) | .45(.18) * |
Provider asked about risky behavior | 2.99(2.05) | 2.85(2.04) | 3.17(2.06) | 3.22(2.04) | 3.34(1.99) | 3.50(1.92) | 3.35(2.06) | 3.55(2.01) | .12(.22) | .06(.24) | .35(.26) |
Parenting pertinent to diversion prevention | |||||||||||
Parental supervision and monitoring specific to ADHD medication | 4.39(.93) | 4.39(.93) | 4.48(.83) | 4.39(.85) | 4.36(.96) | 4.28(1.04) | 4.35(.85) | 4.34(.96) | −.04(.09) | −.07(. 11) | −.06(.10) |
Parent/adolescent communication about diversion | 3.49(3.40) | 3.45(3.51) | 3.84(3.66) | 3.99(3.67) | 3.58(3.70) | 4.53(3.74) | 4.07(3.88) | 4.23(3.80) | .15(.20) | .46(.22) * | −.01(.24) |
Notes. Group n’s for TAU and SDP, respectively, ranged from 173–174 and 159–160 at Time 1, 162–164 and 144–149 at Time 2, 149–162 and 132–151 at Time 3, and 130–158 and 120–145 at Time 4. Significant results from GEE analyses are bolded.
p<.05.